샘플 요청 목록

 카트 문의
시장보고서
상품코드
1808877

심근 트로포닌 시장 : 제품 유형별, 검사 유형별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Cardiac Troponin Market, By Product Type, By Test Type, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 392 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심근 트로포닌 시장 규모는 2024년에 33억 4,512만 달러에 달하며, 2025-2032년에 CAGR 8.5%로 확대했습니다.

심근 트로포닌 시장은 특히 심근경색(심장마비) 등 심근 장애를 감지하는 중요한 바이오마커인 혈중 트로포닌 농도를 측정하는 진단 검사의 제조 및 판매를 중심으로 전개되고 있습니다. 심근 트로포닌(cTnI 및 cTnT)은 심장이 손상을 입었을 때 혈류로 방출되는 단백질로, 심장 사건의 민감하고 구체적인 지표가 됩니다. 심혈관 질환(CVD) 유병률 증가, 조기 및 정확한 진단에 대한 수요 증가, 고감도 트로포닌 측정법(hs-cTn 검사)의 발전이 이 시장을 주도하고 있습니다.

이러한 검사를 통해 심장마비를 조기에 발견하고 환자의 예후를 개선할 수 있습니다. 병원, 진단 실험실, 응급의료센터가 주요 최종 사용처입니다. 주요 기업으로는 Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter 등이 있으며, 기술 혁신과 규제 당국의 승인으로 경쟁하고 있습니다. 고령화, 좌식 생활습관, 심장 건강에 대한 인식이 높아짐에 따라 시장이 확대되고 있습니다. 그러나 높은 비용과 까다로운 규제 요건이 문제점으로 지적되고 있습니다.

심근 트로포닌 시장 - 시장 역학

응급 진단에서 고감도 트로포닌 검사에 대한 수요 증가

심근 트로포닌 시장의 주요 촉진요인 - 이 고급 분석법은 혈액내 미량의 트로포닌을 검출하므로 기존 검사에 비해 심장마비를 조기에 정확하게 진단할 수 있습니다. 응급실에서는 hs-cTn 검사를 통해 심근경색의 신속한 배제 판단을 위해 hs-cTn 검사를 활용하고 있으며, 환자 분류를 개선하고 불필요한 입원을 줄이고 있습니다. 전 세계에서 심혈관 질환(CVD)이 증가하고 있는 가운데, 더 나은 결과를 얻기 위해서는 신속하고 정확한 진단이 필수적입니다. 고감도 검사는 특히 증상이 모호한 비 ST상승형 심근경색증(NSTEMI)에서 신속한 의사결정을 가능하게 합니다. hs-cTn 측정법에 대한 규제 당국의 승인과 그 사용을 권장하는 가이드라인이 시장 성장을 더욱 촉진하고 있습니다.

병원과 진단검사실은 급성기 의료 현장의 효율성을 높이기 위해 이러한 검사를 채택하는 경향이 증가하고 있습니다. 그 결과, 주요 진단 기업은 차세대 hs-cTn 검사에 투자하여 심근 트로포닌 시장의 기술 혁신과 경쟁을 촉진하고 있습니다. 의료 시스템이 보다 신속하고 신뢰할 수 있는 심장 진단을 우선시하는 가운데, 이러한 추세는 앞으로도 계속될 것으로 예측됩니다.

심근 트로포닌 시장 - 주요 인사이트

당사의 리서치 애널리스트들이 공유한 분석에 따르면 세계 시장은 예측 기간(2025-2032년) 동안 매년 약 8.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 추정됩니다.

제품 유형별로는 고감도 심근 트로포닌(hs-cTn) 검사가 2024년 가장 큰 시장 점유율을 차지했습니다.

검사 유형별로는 2024년 트로포닌 i 검사가 주요 검사 유형이었습니다.

최종사용자별로는 2024년 병원과 응급실이 주요 최종사용자로 꼽혔습니다.

지역별로는 북미가 2024년 매출 1위를 차지했습니다.

심근 트로포닌 시장 - 세분화 분석 :

세계 심근 트로포닌 시장은 제품 유형, 검사 유형, 최종사용자 및 지역을 기준으로 세분화됩니다.

시장은 제품 유형에 따라 고감도 심근 트로포닌 검사, 기존 심근 트로포닌 검사, 현장 진료 트로포닌 검사로 분류됩니다. 고감도 심근 트로포닌(hs-cTn) 검사 부문은 심근경색을 조기에 정확하게 진단할 수 있는 우수한 임상적 유용성으로 인해 심근 트로포닌 시장을 독점하고 있습니다. 이러한 고급 분석법은 기존 검사에 비해 혈중 트로포닌 농도를 현저히 낮게 검출할 수 있으므로 의사가 심장질환을 더 빨리, 종종 증상 발현 후 1-2시간 이내에 확인할 수 있습니다. 이러한 신속한 발견은 적시에 개입하여 환자의 예후를 개선하고 사망률을 낮출 수 있는 응급상황에서 매우 중요합니다.

hs-cTn 검사의 우월성은 급성관상동맥증후군 진단에 hs-cTn 검사의 사용을 우선시하는 임상 가이드라인(ESC 및 ACC 권고 등)에 의해 더욱 강화되고 있습니다. 병원과 검사 기관은 진단의 불확실성을 줄이고 불필요한 입원을 최소화하며 워크플로우의 효율성을 높이기 위해 이러한 검사를 점점 더 많이 채택하고 있습니다. 또한 Roche, Abbott, Siemens와 같은 주요 진단 기업은 고감도 분석에 많은 투자를 하고 있으며, 기술 혁신과 시장 침투를 촉진하고 있습니다.

시장은 검사 유형에 따라 트로포닌 I과 트로포닌 T의 두 가지 범주로 나뉩니다. 트로포닌 I(cTnI)은 심근 트로포닌 검사 분야에서 세계 최대 점유율을 차지하고 있습니다. cTnI 검사는 트로포닌 I이 심근에만 발현되므로 골격근의 교차 반응성을 약간 보이는 트로포닌 T와 달리 심근 특이성이 우수합니다. Abbott Laboratories와 Beckman Coulter와 같은 주요 진단 기업은 cTnI 측정에 많은 투자를 하고 있으며, Abbott의 고감도 트로포닌 i 검사는 미국과 유럽에서 시장 선두주자로 자리매김하고 있습니다.

cTnI 부문의 성장은 급성관상동맥증후군에 대한 임상 가이드라인과 표준화된 진단 프로토콜에 널리 채택되면서 더욱 가속화되고 있습니다. 트로포닌 T(로슈의 독자적인 Elecsys 플랫폼에서 거의 관리되는)와 달리, 트로포닌 I 측정법은 여러 제조업체에서 제공되고 있으며, 시장 경쟁이 더욱 치열해지고 있습니다. 또한 cTnI 검사는 신장질환을 가진 환자를 포함한 특정 환자 집단에서 더 우수한 분석 성능을 보입니다. 트로포닌 T는 여전히 중요하지만(특히 로슈가 지배하고 있는 시장에서) 트로포닌 I은 심장 특이적이라는 점, 여러 공급업체에서 공급되고 있다는 점, 그리고 진화하는 고감도 검사 요건에 부합한다는 점에서 현대 심장 의학에서 선호되는 바이오마커로 자리매김하고 있습니다. 바이오마커로서의 입지를 확고히 하고 있습니다.

심근 트로포닌 시장 - 지역적 인사이트

북미 심근 트로포닌 시장은 높은 의료 인프라, 높은 CVD 유병률, 고감도 트로포닌(hs-cTn) 분석법의 급속한 보급으로 인해 전 세계에서 우위를 점하고 있습니다. 미국이 선두를 달리고 있는 것은 강력한 상환 정책, FDA의 첨단 검사 승인, 응급실에서의 보급에 기인합니다.

캐나다는 심장 치료에 대한 투자가 증가하고 hs-cTn 검사를 촉진하는 표준화된 가이드라인이 있으며, 근소한 차이로 뒤를 잇고 있습니다. 애보트, 로슈, 지멘스 등 대형 진단약 제조업체들이 강력한 존재감을 드러내며 경쟁과 기술 혁신에 박차를 가하고 있습니다. 엄격한 규제 기준이 고품질 진단을 보장하는 한편, 심장마비 조기 발견에 대한 인식이 높아지면서 수요가 더욱 증가하고 있습니다. 이 지역은 정밀의료와 AI 통합진단에 중점을 두고 있으며, 앞으로도 시장 성장을 촉진할 것으로 보입니다.

심근 트로포닌 시장 - 경쟁 구도:

심근 트로포닌 시장의 경쟁 환경은 기술 혁신, 규제 승인, 전략적 제휴에 힘입어 세계 진단 대기업 간의 치열한 경쟁으로 특징지어집니다. Abbott Laboratories, Roche Diagnostics, Siemens Healthineers 3사는 첨단 고감도 트로포닌(hs-cTn) 분석법과 강력한 최종사용자 네트워크를 무기로 시장을 독점하고 있습니다. Roche의 Elecsys Troponin T와 Abbott의 Architect STAT hs-Troponin-I가 채택률에서 선두를 달리고 있습니다.

QuidelOrtho, bioMerieux, Beckman Coulter와 같은 중견기업은 현장진단(POCT) 및 자동 검사 시스템과 같은 틈새 부문에 초점을 맞추고 있으며, Randox Laboratories 및 Getein Biotech 같은 신규 기업은 저렴한 대안으로 비용에 민감한 시장을 공략하고 있습니다. 합병과 인수합병(퀴델과 오소임상진단의 합병 등)은 시장을 재편하고 기술력을 강화하는 계기가 되고 있습니다.

목차

제1장 심근 트로포닌 시장 개요

  • 조사 범위
  • 시장 추정연도

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 심근 트로포닌의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 심근 트로포닌 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 지도제작
  • 규제 구조 분석

제5장 심근 트로포닌 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 심근 트로포닌 시장 구도

  • 심근 트로포닌 시장 점유율 분석(2024년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 심근 트로포닌 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 고감도 심근 트로포닌 검사
    • 기존 심근 트로포닌 검사
    • POC(Point-of-Care) 트로포닌 검사

제8장 심근 트로포닌 시장 - 검사 유형별

  • 개요
    • 테스트 유형별 부문 점유율 분석
    • 트로포닌 I
    • 트로포닌 T

제9장 심근 트로포닌 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원과 구급과
    • 진단 및 임상 검사실
    • 외래 수술 센터
    • 기타

제10장 심근 트로포닌 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 심근 트로포닌 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Abbott Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • Beckman Coulter
    • bioMerieux
    • Thermo Fisher Scientific
    • QuidelOrtho
    • Becton Dickinson
    • Sysmex Corporation
    • PerkinElmer
    • Bio-Rad Laboratories
    • Fujirebio
    • DiaSorin
    • Randox Laboratories
    • Tosoh Corporation
    • Ortho Clinical Diagnostics
    • Merck KGaA
    • ELITechGroup
    • Getein Biotech
    • Response Biomedical

제12장 애널리스트의 전방위적 전망

KSA 25.09.24

Cardiac Troponin Market size was valued at US$ 3,345.12 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

The cardiac troponin market revolves around the production and sale of diagnostic tests that measure troponin levels in the blood, which are critical biomarkers for detecting heart muscle damage, particularly in conditions like myocardial infarction (heart attack). Cardiac troponins (cTnI and cTnT) are proteins released into the bloodstream when the heart is injured, making them highly sensitive and specific indicators of cardiac events. The market is driven by the rising prevalence of cardiovascular diseases (CVDs), increasing demand for early and accurate diagnosis, and advancements in high-sensitivity troponin assays (hs-cTn tests).

These tests enable faster detection of heart attacks, improving patient outcomes. Hospitals, diagnostic labs, and emergency care centers are the primary end-users. Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Beckman Coulter, who compete through innovation and regulatory approvals. The market is expanding due to aging populations, sedentary lifestyles, and growing awareness of cardiac health. However, challenges include high costs and stringent regulatory requirements.

Cardiac Troponin Market- Market Dynamics

Rising demand for high-sensitivity troponin tests in emergency diagnostics

Key driver of the cardiac troponin market. These advanced assays detect even minute levels of troponin in the blood, enabling earlier and more accurate diagnosis of heart attacks compared to conventional tests. Emergency departments rely on hs-cTn tests to quickly rule in or rule out myocardial infarction, improving patient triage and reducing unnecessary hospital admissions. With cardiovascular diseases (CVDs) on the rise globally, rapid and precise diagnosis is critical for better outcomes. High-sensitivity tests allow for faster decision-making, particularly in cases of non-ST-elevation myocardial infarction (NSTEMI), where symptoms may be ambiguous. Regulatory approvals for hs-cTn assays, along with guidelines recommending their use, further boost market growth.

Hospitals and diagnostic labs are increasingly adopting these tests to enhance efficiency in acute care settings. As a result, leading diagnostic companies are investing in next-generation hs-cTn tests, driving innovation and competition in the cardiac troponin market. This trend is expected to continue as healthcare systems prioritize faster, more reliable cardiac diagnostics.

Cardiac Troponin Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)

Based on product type segmentation, High-Sensitivity Cardiac Troponin (hs-cTn) Tests were predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Troponin I Tests were the leading Test Type in 2024

Based on End-user segmentation, Hospitals & Emergency Departments were the leading end-users in 2024

Based on region, North America was the leading revenue generator in 2024

Cardiac Troponin Market- Segmentation Analysis:

The Global Cardiac Troponin Market is segmented on the basis of Product Type, Test Type, End-user, and Region.

The market is divided into three categories based on product type: High-Sensitivity Cardiac Troponin Tests, Conventional Cardiac Troponin Tests, and Point-of-Care Troponin Tests. The High-Sensitivity Cardiac Troponin (hs-cTn) Tests segment dominates the cardiac troponin market due to its superior clinical utility in early and accurate diagnosis of myocardial infarction. These advanced assays can detect significantly lower levels of troponin in the blood compared to conventional tests, enabling physicians to identify heart damage much sooner, often within 1-2 hours of symptom onset. This rapid detection is critical in emergency settings, where timely intervention improves patient outcomes and reduces mortality rates.

The dominance of hs-cTn tests is further reinforced by clinical guidelines (e.g., ESC and ACC recommendations) that prioritize their use for diagnosing acute coronary syndromes. Hospitals and labs increasingly adopt these tests because they reduce diagnostic uncertainty, minimize unnecessary hospital admissions, and enhance workflow efficiency. Additionally, leading diagnostic companies like Roche, Abbott, and Siemens heavily invest in high-sensitivity assays, driving innovation and market penetration.

The market is divided into two categories based on Test Type: Troponin I, Troponin T. Troponin I (cTnI) dominates the cardiac troponin test type segment, holding the largest market share globally. This dominance stems from several key advantages: cTnI tests demonstrate superior cardiac specificity since troponin I is expressed exclusively in cardiac muscle, unlike troponin T, which shows minor skeletal muscle cross-reactivity. Major diagnostic players like Abbott Laboratories and Beckman Coulter have heavily invested in cTnI assays, with Abbott's High-Sensitivity Troponin-I test becoming a market leader in the U.S. and Europe.

The cTnI segment's growth is further propelled by its widespread adoption in clinical guidelines and standardized diagnostic protocols for acute coronary syndromes. Unlike troponin T (which is largely controlled by Roche's proprietary Elecsys platform), troponin I assays are available from multiple manufacturers, creating a more competitive market landscape. Additionally, cTnI tests show better analytical performance in certain patient populations, including those with renal disease. While troponin T remains important (particularly in Roche-dominated markets), troponin I's cardiac-specific nature, multi-vendor availability, and alignment with evolving high-sensitivity testing requirements cement its position as the preferred biomarker in modern cardiac care.

Cardiac Troponin Market- Geographical Insights

The North American cardiac troponin market dominates globally, driven by advanced healthcare infrastructure, high CVD prevalence, and rapid adoption of high-sensitivity troponin (hs-cTn) assays. The U.S. leads due to strong reimbursement policies, FDA approvals for advanced tests, and widespread use in emergency departments.

Canada follows closely, with increasing investments in cardiac care and standardized guidelines promoting hs-cTn testing. Major diagnostic players like Abbott, Roche, and Siemens have a strong presence, fueling competition and innovation. Strict regulatory standards ensure high-quality diagnostics, while rising awareness of early heart attack detection further boosts demand. The region's focus on precision medicine and AI-integrated diagnostics will continue shaping market growth.

Cardiac Troponin Market- Competitive Landscape:

The competitive landscape of the cardiac troponin market is characterized by intense rivalry among global diagnostics giants, driven by innovation, regulatory approvals, and strategic partnerships. Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate the market, leveraging their advanced high-sensitivity troponin (hs-cTn) assays and strong End-user networks. These players compete on accuracy, speed, and clinical utility, with Roche's Elecsys Troponin T and Abbott's Architect STAT hs-Troponin-I leading in adoption.

Mid-sized firms like QuidelOrtho, bioMerieux, and Beckman Coulter focus on niche segments, such as point-of-care testing (POCT) and automated lab systems, while emerging players like Randox Laboratories and Getein Biotech target cost-sensitive markets with affordable alternatives. Mergers and acquisitions (e.g., Quidel's merger with Ortho Clinical Diagnostics) are reshaping the market, enhancing technological capabilities.

Recent Developments:

In June 2024, Abbott Laboratories received FDA clearance for its next-gen High-Sensitivity Troponin-I assay on the Alinity ci-series analyzers, enabling faster MI diagnosis in U.S. hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC TROPONIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • bioMerieux
  • Thermo Fisher Scientific
  • QuidelOrtho
  • Becton Dickinson
  • Sysmex Corporation
  • PerkinElmer
  • Bio-Rad Laboratories
  • Fujirebio
  • DiaSorin
  • Randox Laboratories
  • Tosoh Corporation
  • Ortho Clinical Diagnostics
  • Merck KGaA
  • ELITechGroup
  • Getein Biotech
  • Response Biomedical

GLOBAL CARDIAC TROPONIN MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • High-Sensitivity Cardiac Troponin Tests
  • Conventional Cardiac Troponin Tests
  • Point-of-Care Troponin Tests

GLOBAL CARDIAC TROPONIN MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Troponin I
  • Troponin T

GLOBAL CARDIAC TROPONIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Emergency Departments
  • Diagnostic & Clinical Laboratories
  • Ambulatory Surgical Centers
  • Others

GLOBAL CARDIAC TROPONIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiac Troponin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiac Troponin Market Snippet by Product Type
    • 2.1.2. Cardiac Troponin Market Snippet by Test Type
    • 2.1.3. Cardiac Troponin Market Snippet by End-user
    • 2.1.4. Cardiac Troponin Market Snippet by Country
    • 2.1.5. Cardiac Troponin Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiac Troponin Key Market Trends

  • 3.1. Cardiac Troponin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiac Troponin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiac Troponin Market Opportunities
  • 3.4. Cardiac Troponin Market Future Trends

4. Cardiac Troponin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiac Troponin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cardiac Troponin Market Landscape

  • 6.1. Cardiac Troponin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiac Troponin Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. High-Sensitivity Cardiac Troponin Tests
    • 7.1.3. Conventional Cardiac Troponin Tests
    • 7.1.4. Point-of-Care Troponin Tests

8. Cardiac Troponin Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Troponin I
    • 8.1.3. Troponin T

9. Cardiac Troponin Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Emergency Departments
    • 9.1.3. Diagnostic & Clinical Laboratories
    • 9.1.4. Ambulatory Surgical Centers
    • 9.1.5. Others

10. Cardiac Troponin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cardiac Troponin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cardiac Troponin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cardiac Troponin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cardiac Troponin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cardiac Troponin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cardiac Troponin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Siemens Healthineers
    • 11.2.4. Beckman Coulter
    • 11.2.5. bioMerieux
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. QuidelOrtho
    • 11.2.8. Becton Dickinson
    • 11.2.9. Sysmex Corporation
    • 11.2.10. PerkinElmer
    • 11.2.11. Bio-Rad Laboratories
    • 11.2.12. Fujirebio
    • 11.2.13. DiaSorin
    • 11.2.14. Randox Laboratories
    • 11.2.15. Tosoh Corporation
    • 11.2.16. Ortho Clinical Diagnostics
    • 11.2.17. Merck KGaA
    • 11.2.18. ELITechGroup
    • 11.2.19. Getein Biotech
    • 11.2.20. Response Biomedical

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제